Alan Grujic - 07 Mar 2023 Form 3 Insider Report for GUIDED THERAPEUTICS INC (GTHP)

Role
Director
Signature
/s/ Alan Grujic
Issuer symbol
GTHP
Transactions as of
07 Mar 2023
Transactions value $
$0
Form type
3
Filing time
20 Jun 2023, 14:50:03 UTC
Next filing
11 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GTHP Common Stock 1,388,909 07 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GTHP Series E Preferred Stock 07 Mar 2023 Common Stock 50 $4,000 Direct F2
holding GTHP Warrants to Purchase Common Stock 07 Mar 2023 Common Stock 500,000 $0.5 Direct
holding GTHP Warrants to Purchase Common Stock 07 Mar 2023 Common Stock 500,000 $0.65 Direct
holding GTHP Warrants to Purchase Common Stock 07 Mar 2023 Common stock 800,000 $0.5 Direct
holding GTHP Stock Option (right to buy) 07 Mar 2023 Common Stock 100,000 $0.27 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares subject to the award vested on March 7, 2023; the remaining shares will vest monthly, starting 90 days from the grant date, subject to the reporting person's continued service on each such date, until the award is fully vested on March 7, 2026.
F2 These securities consist of Series E Convertible Preferred Stock ("Series E Preferred") of the Issuer that are presently convertible on a 1-for-4,000 basis into Common Stock without payment or further consideration. The Series E Preferred shares are convertible at any time for a period of five years after issuance. The Series E Preferred have no expiration date.